Related Experiment Video
Updated: Jun 27, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Pharmacologic management of hypertension in patients with diabetes
Karen L Whalen1, Robert D Stewart
1University of Florida College of Pharmacy-St Petersburg Campus, Seminole 33772, USA. whalen@cop.ufl.edu
Insights
Managing hypertension in diabetes patients is crucial for preventing complications. Target blood pressure should be below 130/80 mm Hg, often requiring combination therapy with preferred agents like ACE inhibitors.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Hypertension is a frequent comorbidity in patients with diabetes.
- Effective blood pressure control is essential for reducing macrovascular and microvascular complications.
Purpose of the Study:
- To outline the recommended blood pressure targets and therapeutic strategies for patients with diabetes and hypertension.
- To discuss the roles of various antihypertensive drug classes in managing this patient population.
Main Methods:
- Review of current guidelines and evidence regarding hypertension management in diabetes.
- Analysis of the efficacy and safety profiles of different antihypertensive agents.
Main Results:
- A target blood pressure of less than 130/80 mm Hg is recommended for patients with diabetes.
- Angiotensin-converting enzyme inhibitors are preferred, with angiotensin receptor blockers as a first-line alternative.
- Combination therapy with multiple agents is often necessary to achieve blood pressure goals.
Conclusions:
- Optimal blood pressure control in diabetic patients significantly mitigates risks of serious complications.
- Specific antihypertensive agents, particularly ACE inhibitors and ARBs, play a key role in preserving kidney function and cardiovascular health.
- A tailored, often multi-drug approach is required for effective hypertension management in diabetes.
Abstract:
Hypertension is a common comorbidity in patients with diabetes, and adequate control of blood pressure significantly reduces the risk of macrovascular and microvascular complications. Patients with diabetes should achieve a target blood pressure of less than 130/80 mm Hg. The use of angiotensin-converting enzyme inhibitors may slow progression to kidney failure and cardiovascular mortality; these agents are the preferred therapy for managing coexisting diabetes and hypertension. Angiotensin receptor blockers can prevent progression of diabetic kidney disease and are a first-line alternative for patients intolerant of angiotensin-converting enzyme inhibitors. Thiazide diuretics provide additional antihypertensive effects when combined with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. With lower doses of these drugs, the risk of clinically significant metabolic alterations is minimal. Beta blockers and calcium channel blockers also have beneficial effects in managing hypertension in patients with diabetes. Beta blockers reduce cardiovascular events and are useful in a multidrug regimen. Dihydropyridine calcium channel blockers should be reserved for patients intolerant of preferred agents or those who need additional therapy to achieve target blood pressure. Many patients with diabetes require combination therapy with multiple antihypertensive agents.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Antihypertensive Drugs: Action of Diuretics
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System